Dolly Vance | Executive Vice President, Corporate Affairs & General Counsel |
Raul Rodriguez | Chief Executive Officer |
Tarek Sallam | Vice President, Marketing |
Wolfgang Dummer | Chief Medical Officer |
Dean Schorno | Chief Financial Officer |
Yigal Nochomovitz | Citigroup |
Nicole Gabreski | Piper Sandler |
Joe Pantginis | H.C. Wainwright |
Tessa Romero | JPMorgan |
Kristen Kluska | Cantor Fitzgerald |
Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the Second Quarter 2020. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel.